Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc

Bullboard Posts

Comment by longterm56on Sep 10, 2020 3:01pm

108 Views

Post# 31534564

RE:RE:Today's news is a gigantic development

If the market cap stays this low ... we should all combine our shares and take this private. $200M market cap is insane.

-LT

Scioto wrote:
I agree. Good news. However, the company must work hard to tell the story. I do believe they are improving their marketing savvy, but these are difficult times - lot of companies big and small competing for the headlines and analyst attention. Another big day and a growing wave of evidence that this company is on the move up.

Bullboard Posts

3 Mid-Sized Stocks to Consider This Season